N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury

被引:11
作者
Genovese, Tiziana
Mazzon, Emanuela
Esposito, Emanuela
Muia, Carmelo
Di Paola, Rosanna
Crisafulli, Concetta
Bramanti, Placido
Cuzzocrea, Salvatore
机构
[1] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, I-98100 Messina, Italy
[2] IRCCS Ctr Neuro Bonino Pulejo, Messina, Italy
[3] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy
来源
SHOCK | 2007年 / 27卷 / 03期
关键词
z-VAD-fmk; caspases; injury; apoptosis; spinal cord injury;
D O I
10.1097/01.shk.0000239775.41022.54
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
The aim of this study was to investigate the effects of N-benzyloxycarbonyl-Val-Ala-Asp-fIuoromethylketones (z-VAD-fmk) on the degree of experimental spinal cord trauma induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. Spinal cord injury in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of a range of inflammatory mediators, tissue damage, and apoptosis. Treatment of the mice with z-VAD-fmk, a potent broad specific caspase inhibitor, significantly reduced the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) neutrophil infiltration (myeloperoxidase activity), (3) nitrotyrosine formation, and (4),apoptosis (TUNEL staining and Bax and Bcl-2 expression). In a separate set of experiments, z-VAD-fmk significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly demonstrate that treatment with z-VAD-fmk reduces the development of inflammation and tissue injury associated with spinal cord trauma.
引用
收藏
页码:258 / 265
页数:8
相关论文
共 55 条
[1]
The role of nitric oxide in tissue destruction [J].
Abramson, SB ;
Amin, AR ;
Clancy, RM ;
Attur, M .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2001, 15 (05) :831-845
[2]
Cytokines and acute neurodegeneration [J].
Allan, SM ;
Rothwell, NJ .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (10) :734-744
[3]
Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury [J].
Amar, AP ;
Levy, ML .
NEUROSURGERY, 1999, 44 (05) :1027-1039
[4]
Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO
[5]
2-7
[6]
METHYLPREDNISOLONE INHIBITS EARLY INFLAMMATORY PROCESSES BUT NOT ISCHEMIC CELL-DEATH AFTER EXPERIMENTAL SPINAL-CORD LESION IN THE RAT [J].
BARTHOLDI, D ;
SCHWAB, ME .
BRAIN RESEARCH, 1995, 672 (1-2) :177-186
[7]
A SENSITIVE AND RELIABLE LOCOMOTOR RATING-SCALE FOR OPEN-FIELD TESTING IN RATS [J].
BASSO, DM ;
BEATTIE, MS ;
BRESNAHAN, JC .
JOURNAL OF NEUROTRAUMA, 1995, 12 (01) :1-21
[8]
Beattie MS, 2002, PROG BRAIN RES, V137, P37
[9]
Review of current evidence for apoptosis after spinal cord injury [J].
Beattie, MS ;
Farooqui, AA ;
Bresnahan, JC .
JOURNAL OF NEUROTRAUMA, 2000, 17 (10) :915-925
[10]